Treatment of Port-wine Mark in Sturge-Weber Syndrome Using Topical Timolol

Recruiting

Phase 1 Results N/A

Summary of Purpose

Primary Objective: • To assess the possible utility of topical timolol in the management of port-wine mark (PWM) in Sturge-Weber syndrome in children.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 12 May 2017.

1 Feb 2012 11 Feb 2012 1 Dec 2017 1 Jun 2018 1 May 2017 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Design

  • Allocation: Randomized
  • Masking: Double Blind (Subject, Caregiver)
  • Purpose: Treatment
  • Endpoint: Safety/Efficacy Study
  • Intervention: Parallel Assignment

Contacts

See All